Breaking the Vicious Cycle: ETH Zurich Researchers Discover Promising Alzheimer’s Compound That Targets GRK2 Aggregates
In the global battle against neurodegenerative disorders, researchers at ETH Zurich have unveiled a preclinical breakthrough that could fundamentally alter…